No Increased Risk of Taking Additional Intestinal Mucosal Research Biopsies From the Duodenum During Pediatric Endoscopy.


Journal

Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545

Informations de publication

Date de publication:
01 04 2023
Historique:
pmc-release: 01 04 2024
pubmed: 28 1 2023
medline: 25 3 2023
entrez: 27 1 2023
Statut: ppublish

Résumé

Studies involving human intestinal tissue are essential for advancing the field of celiac disease (CeD), as diagnosis requires duodenal biopsies. Performing studies in children helps to better understand CeD in this important subpopulation. This study aims to determine the risk in obtaining duodenal research biopsies during pediatric endoscopy. In this retrospective chart review from 2016 to 2022 of 1180 research subjects and controls, there were 18 procedure-related adverse events within 48 hours. Most adverse events were for symptoms of pain and fever. There was no increased risk of adverse events if additional duodenal research biopsies were taken during pediatric endoscopy.

Identifiants

pubmed: 36705668
doi: 10.1097/MPG.0000000000003723
pii: 00005176-202304000-00017
pmc: PMC10038907
mid: NIHMS1868000
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

480-482

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK122127
Pays : United States

Informations de copyright

Copyright © 2023 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Déclaration de conflit d'intérêts

M.M.L. served on an advisory board for Mozart Therapeutics and 9Meters Biopharma and acted as a consultant for Anokion. She has served as site-PI for Takeda Pharmaceuticals. The remaining authors report no conflicts of interest.

Références

Husby S, Koletzko S, Korponay-Szabó I, et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr 2020;70:141–56.
Tarar ZI, Zafar MU, Farooq U, et al. The progression of celiac disease, diagnostic modalities, and treatment options. J Investig Med High Impact Case Rep 2021;9:23247096211053702.
Yao MD, von Rosenvinge EC, Groden C, Mannon PJ. Multiple endoscopic biopsies in research subjects: safety results from a National Institutes of Health series. Gastrointest Endosc 2009;69:906–10.
Hill ID, Fasano A, Guandalini S, et al. NASPGHAN clinical report on the diagnosis and treatment of gluten-related disorders. J Pediatr Gastroenterol Nutr 2016;63:156–65.
Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010;71:446–54.
Thakkar K, El-Serag HB, Mattek N, Gilger MA. Complications of pediatric EGD: a 4-year experience in PEDS-CORI. Gastrointest Endosc 2007;65:213–21.
Moran CJ, Noreck J, Winter HS, et al. Additional intestinal mucosal biopsy sampling for research is safe during pediatric endoscopic procedures. Clin Gastroenterol Hepatol 2020;18:1233–4.
Mahadev S, Murray JA, Wu T-T, et al. Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free diet. Aliment Pharmacol Ther 2017;45:1084–93.
Serena G, D’Avino P, Fasano A. Celiac disease and non-celiac wheat sensitivity: state of art of non-dietary therapies. Front Nutr 2020;7:152.

Auteurs

Tracey M DaFonte (TM)

From the Division of Pediatric Gastroenterology, Department of Pediatrics, MassGeneral Hospital for Children, Harvard Medical School, Boston, MA.
the Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA.
the Center for Celiac Research and Treatment, Massachusetts General Hospital, Boston, MA.

Elizabeth Gleeson (E)

the Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA.
the Center for Celiac Research and Treatment, Massachusetts General Hospital, Boston, MA.

Taylor Morson (T)

the Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA.
the Center for Celiac Research and Treatment, Massachusetts General Hospital, Boston, MA.

Katherine L Olshan (KL)

From the Division of Pediatric Gastroenterology, Department of Pediatrics, MassGeneral Hospital for Children, Harvard Medical School, Boston, MA.
the Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA.
the Center for Celiac Research and Treatment, Massachusetts General Hospital, Boston, MA.

Christopher J Moran (CJ)

From the Division of Pediatric Gastroenterology, Department of Pediatrics, MassGeneral Hospital for Children, Harvard Medical School, Boston, MA.

Maureen M Leonard (MM)

From the Division of Pediatric Gastroenterology, Department of Pediatrics, MassGeneral Hospital for Children, Harvard Medical School, Boston, MA.
the Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA.
the Center for Celiac Research and Treatment, Massachusetts General Hospital, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH